USE OF AN ERYTHROPOIETIC MOLECULE COVALENTLY LINKED TO POLY(ETHYLENE GLYCOL) GROUPS FOR THE PRODUCTION OF A MEDICAMENT FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS AND SAID SUCH MEDICAMENT
- 专利权人:
- F. HOFFMANN-LA ROCHE AG
- 发明人:
- 申请号:
- IL18985308
- 公开号:
- IL189853A
- 申请日:
- 2008.02.28
- 申请国别(地区):
- IL
- 年份:
- 2012
- 代理人:
- 摘要:
- A method of treating neurodegenerative disorders of the brain and spinal cord using a novel ethropoietic agent.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- MEDICINAL AGENT FOR PREVENTING AND TREATING CEREBRAL DISEASES AND METHOD OF TREATING CEREBRAL DISEASES
- SOLUBLE FC GAMMA RECEPTOR FOR TREATMENT OF AUTOIMMUNE BULLOUS DISEASES
- USE OF MITOCHONDRIALLY-ADDRESSED COMPOUNDS FOR PREVENTING AND TREATING CARDIOVASCULAR DISEASES
- PHYTOTHERAPEUTIC AGENT OF PLANT ORIGIN FOR THE TREATMENT OF CARDIOVASCULAR SYSTEM DISEASES
- Use of mitochondrially-addressed compounds for preventing and treating cardiovascular diseases